Latest Articles
-
For Love and Money: Three Growth Stocks from Casey’s Alex Daley
Submitted by The Life Sciences Report as part of our contributors program . This interview was conducted by George S. Mack of The Life Sciences Report (6/13/13) Alex Daley, senior editor of Casey Extraordinary Technology, seeks out undiscove...
-
Medtronic’s Defibrillators Sales Show A Pulse In Encouraging Results
Medtronic (NYSE:MDT) announced its fourth quarter earnings for fiscal 2013 on Tuesday, reporting 4% growth in revenues that reached $4.45 billion. While its spinal franchise continued to see a decline in sales, what comes as a positive surprise i...
-
Medtronic Q4 Earnings: Modest Revenue Growth And Gross Margin Pressure Expected
Medtronic (NYSE:MDT) is set to announce its Q4 earnings for fiscal 2013 Tuesday, May 21. We expect mid-single digit growth in revenues, even as its key Pacemakers & Defibrillators and Spinal franchises will continue to register a drop in re...
-
Medtronic: A Look At The Spinal Division
Medtronic (NYSE:MDT) is one of the largest medical device makers globally with a leadership position in many markets, including spinal. The spinal market consists of devices and implants for conditions relating to the spine and the musculoskeleta...
-
These 20 Dividend Champions Have The Highest Profitability On The Market
Submitted by Dividend Yield as part of our contributors program . Dividend stocks from the services sector with very low forward P/E ratios originally published at “ long-term-investments.blogspot.com “. Recently I made a screen of...
-
20 Dividend Champions With Highest 10-Year Dividend Growth Rates
Submitted by Dividend Yield as part of our contributors program . Dividend Champions with fastest 10 year dividend growth originally published at “ long-term-investments.blogspot.com “. Dividend Champions are popular because of the...
-
20 Best Yielding Healthcare Stocks Less Volatile Than The Market
Submitted by Dividend Yield as part of our contributors program . This month I like to show you the best yielding large cap stocks from all sectors that are less volatile than the market. I will start today with the healthcare sector. It̵...
-
Medtronic: A Look At The Cardiovascular Market
Despite facing various challenges like declining demand, intense competition and pricing pressure in many of its businesses, Medtronic (NYSE:MDT) has fared relatively better than most of its peers. This is due to strong growth exhibited by its ca...
-
Medtronic: A Look At The Cardiac Rhythm Management Division
Medtronic (NYSE:MDT) is one of the largest medical device makers globally with a leadership position in the Cardiac Rhythm Management (CRM) market. CRM products help in the treatment of abnormal heart conditions by the use of pacemakers and imp...
-
25 Top Stocks And Funds With Recent Dividend Growth
Submitted by Dividend Yield as part of our contributors program . Last week, 25 companies announced to raise their dividend distributions to shareholders. Many REITs and closed-end funds are on the list of the growth stocks. My favorite is Ge...
-
What Will Boost Medtech Stocks? Look for a Better Mousetrap, Says William Plovanic
Submitted by The Life Sciences Report as part of our contributors program . This interview was conducted by George S. Mack of The Life Sciences Report (2/21/13) Growth in the medical technology industry may have slowed, and governmental hurd...
-
Medtronic Earnings Meet Expectations But European Weakness A Concern
Medtronic (NYSE:MDT) announced its third quarter earnings for fiscal 2013 on Tuesday, registering mid-single digit growth in revenues, in-line with our expectations. Overall revenue grew by 4% to $4 billion, excluding the currency impact. The med...
-
Weekly Healthcare Notes: Medtronic & Merck
The past week has been a handful of events for the healthcare sector impacting many healthcare companies under our coverage. Medtronic ‘s (NYSE:MDT) brain stimulation devices have shown impressive efficacy in early-stage Parkinson patients....
-
Medtronic Earnings Will Highlight Improving Sales Outlook Despite Pricing Pressures
Medtronic (NYSE:MDT) is set to announce its Q3 earnings for fiscal 2013 Tuesday, February 19. While we expect its key pacemakers & defibrillators and spinal divisions to continue to register a drop in revenues, the growth in cardiovascular, ...
-
How Medtronic Could Justify A $55 Stock Value
Medtronic’s (NYSE:MDT) stock has appreciated almost 15% this year amidst share purchases of medical device makers and has exceeded our $46 price estimate . Boston Scientific’s earnings fueled positive sentiment regarding the overall b...
